Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William E Carson

Showing results (51-60 of 272) with videos related to

Pageof 28
Sort By:
Nanomedicine : Nanotechnology, Biology, and Medicine|December 29, 2022
Nipple fluid for breast cancer diagnosis using the nanopore of Phi29 DNA-packaging motorLong Zhang, Nicolas Burns, Zhouxiang Ji, et al.
Cellular Immunology|May 24, 2011
Psychological stress is associated with altered levels of myeloid-derived suppressor cells in breast cancer patientsBethany L Mundy-Bosse, Lisa M Thornton, Hae-Chung Yang, et al.
Cancer Immunology Research|January 8, 2026
Phase II trial of interleukin-12 followed by interferon alfa-2b in patients with metastatic malignant melanoma: Results from CALGB 500001 (Alliance)Alvin Liu, Courtney Johnson, Donna Niedzwiecki, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 9, 2017
Diffusion mapping of drug targets on disease signaling network elements reveals drug combination strategiesJielin Xu, Kelly Regan-Fendt, Siyuan Deng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2004
IL-12 pretreatments enhance IFN-alpha-induced Janus kinase-STAT signaling and potentiate the antitumor effects of IFN-alpha in a murine model of malignant melanomaGregory B Lesinski, Brian Badgwell, Jason Zimmerer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2003
A chimeric multi-human epidermal growth factor receptor-2 B cell epitope peptide vaccine mediates superior antitumor responsesNaveen K Dakappagari, John Pyles, Robin Parihar, et al.
Journal of the National Cancer Institute|September 2, 2004
Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapyGregory B Lesinski, Sri Vidya Kondadasula, Tim Crespin, et al.
Surgical Oncology|December 23, 2015
Increased visceral to subcutaneous fat ratio is associated with decreased overall survival in patients with metastatic melanoma receiving anti-angiogenic therapyValerie P Grignol, Andrew D Smith, Darya Shlapak, et al.
Hereditary Cancer in Clinical Practice|April 10, 2019
Increased breast cancer risk in women with neurofibromatosis type 1: a meta-analysis and systematic review of the literatureLorena P Suarez-Kelly, Lianbo Yu, David Kline, et al.
Behavioural Brain Research|May 9, 2017
Novel rodent model of breast cancer survival with persistent anxiety-like behavior and inflammationLeah M Pyter, Lorena P Suarez-Kelly, William E Carson, et al.
Pageof 28

Showing results (51-60 of 272) with videos related to

Sort By:
Pageof 28
Nanomedicine : Nanotechnology, Biology, and Medicine|December 29, 2022
Nipple fluid for breast cancer diagnosis using the nanopore of Phi29 DNA-packaging motorLong Zhang, Nicolas Burns, Zhouxiang Ji, et al.
Cellular Immunology|May 24, 2011
Psychological stress is associated with altered levels of myeloid-derived suppressor cells in breast cancer patientsBethany L Mundy-Bosse, Lisa M Thornton, Hae-Chung Yang, et al.
Cancer Immunology Research|January 8, 2026
Phase II trial of interleukin-12 followed by interferon alfa-2b in patients with metastatic malignant melanoma: Results from CALGB 500001 (Alliance)Alvin Liu, Courtney Johnson, Donna Niedzwiecki, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 9, 2017
Diffusion mapping of drug targets on disease signaling network elements reveals drug combination strategiesJielin Xu, Kelly Regan-Fendt, Siyuan Deng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2004
IL-12 pretreatments enhance IFN-alpha-induced Janus kinase-STAT signaling and potentiate the antitumor effects of IFN-alpha in a murine model of malignant melanomaGregory B Lesinski, Brian Badgwell, Jason Zimmerer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2003
A chimeric multi-human epidermal growth factor receptor-2 B cell epitope peptide vaccine mediates superior antitumor responsesNaveen K Dakappagari, John Pyles, Robin Parihar, et al.
Journal of the National Cancer Institute|September 2, 2004
Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapyGregory B Lesinski, Sri Vidya Kondadasula, Tim Crespin, et al.
Surgical Oncology|December 23, 2015
Increased visceral to subcutaneous fat ratio is associated with decreased overall survival in patients with metastatic melanoma receiving anti-angiogenic therapyValerie P Grignol, Andrew D Smith, Darya Shlapak, et al.
Hereditary Cancer in Clinical Practice|April 10, 2019
Increased breast cancer risk in women with neurofibromatosis type 1: a meta-analysis and systematic review of the literatureLorena P Suarez-Kelly, Lianbo Yu, David Kline, et al.
Behavioural Brain Research|May 9, 2017
Novel rodent model of breast cancer survival with persistent anxiety-like behavior and inflammationLeah M Pyter, Lorena P Suarez-Kelly, William E Carson, et al.
Pageof 28